SCHEMBL19785949

SCHEMBL19785949

C=CC1=CNC(O)C(C(=O)Nc2cccc(Cl)c2C#N)=C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.38
TAS1R1 Q7RTX1 2/20 0.38
TAS1R2 Q8TE23 2/20 0.38
HPGD P15428 3/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C19 P33261 1/20 0.33
CXCR1 P25024 1/20 0.32
CXCR2 P25025 1/20 0.32
NPC1 O15118 3/20 0.32
RAB9A P51151 3/20 0.32
MAPT P10636 3/20 0.32
KDM4E B2RXH2 3/20 0.32
L3MBTL1 Q9Y468 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MAPK1 P28482 1/20 0.32
CACNA1B Q00975 1/20 0.32
APBA1 Q02410 1/20 0.32
MEN1 O00255 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HTT P42858 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19785950 0.69 TAS1R3 (0.45) TAS1R3TAS1R1TAS1R2HPGDCYP1A2
SCHEMBL10767715 0.66 TAS1R3 (0.46) TAS1R3TAS1R1TAS1R2HPGDCYP1A2
SCHEMBL11791658 0.65 GPR35 (0.59) TAS1R3TAS1R1TAS1R2CXCR1CXCR2
SCHEMBL28718277 0.64 TAS1R3 (0.42) TAS1R3TAS1R1TAS1R2CYP1A2CYP2C19
SCHEMBL29670968 0.64 TAS1R3 (0.42) TAS1R3TAS1R1TAS1R2CYP1A2CYP2C19
SCHEMBL19779431 0.64 TAS1R3 (0.43) TAS1R3TAS1R1TAS1R2HPGDCYP1A2
SCHEMBL27371005 0.62 MEN1 (0.50) TAS1R3TAS1R1TAS1R2CYP1A2CYP2C19
SCHEMBL27370682 0.62 TAS1R3 (0.37) TAS1R3TAS1R1TAS1R2HPGDCYP1A2
SCHEMBL19785829 0.62 TAS1R3 (0.46) TAS1R3TAS1R1TAS1R2HPGDCYP1A2
SCHEMBL19785982 0.61 KDR (0.55) TAS1R3TAS1R1TAS1R2HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018013789-A1 HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS INCYTE CORPORATION (US) 2018-01-18 WO disclosed